EU research project to improve Hepatitis C treatment services

Irish researchers secure €1.8 million through the Third EU Public Health Programme for research on Hepatitis C.

'This project is a great example of how Irish clinicians and service providers can benefit from European collaboration' said Dr Graham Love, Chief Executive of the Health Research Board.

‘There is real benefit from becoming involved in such European initiatives’ he added. ‘Many disease challenges transcend Irish borders and Irish citizens will derive real treatment benefit from projects like HepCare Europe, that take a collective approach to developing effective models of treatment and care. 

We particularly welcome the partnership approach being taken in this project to applying novel diagnostics and treatments in a community health care setting’ said Dr Love. ‘This is very much in keeping with our strategic goal of supporting multi-sectoral and multidisciplinary partnerships to tackle Irish health care problems, and ensure that research findings are translated into tangible benefits for Irish citizens'.

The HRB provides the National Focal Point for the EU Public Health Programme, and through this activity works to encourage and facilitate Irish practitioners and policy makers to tap into the broader expertise available at a European level.

Information on EU funding and the support that the HRB provides for applicants is available from the HRB website at

More details on the research project itself, (HepCare Europe), will be available shortly on the UCD website at